Five new chemical entities (NCEs) were registered with the Therapeutic Goods Administration during August.
They include an Hep C treatment from MSD, a non-small cell lung cancer treatment from Astra, an UCB treatment for epilepsy and allergy treatments from Seqirus.
Go to www.tga.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 02 Sep 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 Sep 16